Rigel Pharmaceuticals Inc (RIGL)
25.04
+0.73
(+3.00%)
USD |
NASDAQ |
Nov 21, 16:00
25.11
+0.07
(+0.28%)
After-Hours: 20:00
Rigel Pharmaceuticals Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 29, 2022 | 26.07 |
| June 28, 2022 | 27.59 |
| June 27, 2022 | 30.88 |
| June 24, 2022 | 25.82 |
| June 23, 2022 | 28.35 |
| June 22, 2022 | 30.88 |
| June 21, 2022 | 30.12 |
| June 17, 2022 | 27.84 |
| June 16, 2022 | 24.68 |
| June 15, 2022 | 20.62 |
| June 14, 2022 | 18.55 |
| June 13, 2022 | 17.55 |
| June 10, 2022 | 17.03 |
| June 09, 2022 | 18.16 |
| June 08, 2022 | 17.73 |
| June 07, 2022 | 44.54 |
| June 06, 2022 | 41.76 |
| June 03, 2022 | 43.03 |
| June 02, 2022 | 42.01 |
| June 01, 2022 | 44.04 |
| May 31, 2022 | 45.81 |
| May 27, 2022 | 47.83 |
| May 26, 2022 | 45.56 |
| May 25, 2022 | 47.33 |
| May 24, 2022 | 46.82 |
| Date | Value |
|---|---|
| May 23, 2022 | 50.11 |
| May 20, 2022 | 50.87 |
| May 19, 2022 | 53.66 |
| May 18, 2022 | 54.16 |
| May 17, 2022 | 55.93 |
| May 16, 2022 | 51.88 |
| May 13, 2022 | 49.61 |
| May 12, 2022 | 46.57 |
| May 11, 2022 | 47.33 |
| May 10, 2022 | 52.39 |
| May 09, 2022 | 49.86 |
| May 06, 2022 | 56.19 |
| May 05, 2022 | 61.25 |
| May 04, 2022 | 66.82 |
| May 03, 2022 | 62.77 |
| May 02, 2022 | 62.26 |
| April 29, 2022 | 59.73 |
| April 28, 2022 | 62.00 |
| April 27, 2022 | 62.00 |
| April 26, 2022 | 63.78 |
| April 25, 2022 | 67.07 |
| April 22, 2022 | 67.57 |
| April 21, 2022 | 68.08 |
| April 20, 2022 | 69.60 |
| April 19, 2022 | 71.88 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.028
Minimum
Apr 01 2020
80.73
Maximum
Apr 01 2022
13.74
Average
9.210
Median
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.299 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.263 |
| Theriva Biologics Inc | 0.1446 |
| Oragenics Inc | 2.226 |
Price to Book Value Related Metrics
| PE Ratio | 108.87 |
| PS Ratio | 2.789 |
| Price to Free Cash Flow | 42.40 |
| Price | 25.04 |
| Earnings Yield | 0.92% |
| Market Cap | 441.08M |
| Operating PE Ratio | 46.22 |
| Normalized PE Ratio | 108.87 |